PRESS RELEASE published on 02/21/2023 at 14:30, 2 years ago Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 02/09/2023 at 14:30, 2 years 1 month ago Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.
PRESS RELEASE published on 02/08/2023 at 14:30, 2 years 1 month ago Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement
PRESS RELEASE published on 02/01/2023 at 15:45, 2 years 1 month ago Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
PRESS RELEASE published on 02/01/2023 at 14:30, 2 years 1 month ago Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
PRESS RELEASE published on 01/30/2023 at 14:30, 2 years 1 month ago Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
PRESS RELEASE published on 01/27/2023 at 22:15, 2 years 1 month ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 01/26/2023 at 14:30, 2 years 1 month ago Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
PRESS RELEASE published on 01/25/2023 at 14:30, 2 years 1 month ago Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
PRESS RELEASE published on 01/23/2023 at 14:30, 2 years 1 month ago Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
Published on 03/18/2025 at 02:00, 6 hours 45 minutes ago Gold Mountain Reports its Interim Q4 2025 Financial and Operating Results
Published on 03/18/2025 at 01:00, 7 hours 45 minutes ago Gold Mountain Announces Change in Financial Year-End
Published on 03/17/2025 at 23:15, 9 hours 30 minutes ago Presentation to Swiss Mining Institute Conference
Published on 03/17/2025 at 22:00, 10 hours 45 minutes ago Tecogen Announces Fourth Quarter and Year-End 2024 Results
Published on 03/17/2025 at 21:30, 11 hours 15 minutes ago Commerce Resources Announces Change in Management
Published on 03/18/2025 at 08:01, 44 minutes ago Genel Energy PLC: Genel Energy to Hold Fixed Income Investor Meetings
Published on 03/18/2025 at 08:00, 45 minutes ago Multitude Group partners with fintech Hoovi to provide EUR 8 million in debt capital
Published on 03/18/2025 at 08:00, 45 minutes ago Genel Energy PLC: Audited results for the year ended 31 December 2024
Published on 03/18/2025 at 08:30, 15 minutes ago Cie du Bois Sauvage: Buy back of own shares – week from 10/03/2025 to 14/03/2025
Published on 03/18/2025 at 07:01, 1 hour 44 minutes ago bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance
Published on 03/18/2025 at 07:00, 1 hour 45 minutes ago Peugeot Invest successfully sold half of its stake in SPIE
Published on 03/17/2025 at 19:15, 13 hours 30 minutes ago OLIVIER MILLET, MEMBER OF THE EXECUTIVE BOARD, STEPS DOWN AS PART OF A SUCCESSFUL MANAGEMENT TRANSITION
